patient_id	diagnosis	specific_diagnosis	lab_id	specimen_type	run_type	inhibitor	replicant	well_concentration	normalized_viability	time_of_read	id
2611	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	16-00310	Peripheral Blood	Standard	Gefitinib	2	10	61.76513622928	24	2611-Gefitinib-2-16-00310
2611	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	16-00310	Peripheral Blood	Standard	Gefitinib	2	3.33333	83.0327192195682	24	2611-Gefitinib-2-16-00310
2611	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	16-00310	Peripheral Blood	Standard	Gefitinib	2	1.11111	104.937056191601	24	2611-Gefitinib-2-16-00310
2611	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	16-00310	Peripheral Blood	Standard	Gefitinib	2	0.37037	127.350796349031	24	2611-Gefitinib-2-16-00310
2611	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	16-00310	Peripheral Blood	Standard	Gefitinib	2	0.123457	79.2121953290973	24	2611-Gefitinib-2-16-00310
2611	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	16-00310	Peripheral Blood	Standard	Gefitinib	2	0.041152	143.142295096311	24	2611-Gefitinib-2-16-00310
2611	ACUTE MYELOID LEUKAEMIA (AML) AND RELATED PRECURSOR NEOPLASMS	AML with mutated NPM1	16-00310	Peripheral Blood	Standard	Gefitinib	2	0.013717	247.824649695214	24	2611-Gefitinib-2-16-00310
